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DOI 10.1016/j.stem.2008.05.011Recent breakthroughs in using viral trans-
duction of a few genes for the reprogram-
ming of both mouse and human somatic
cells into induced pluripotent stem (iPS)
cells have opened up tremendous oppor-
tunities for the stem cell field (Maherali
et al., 2007; Meissner et al., 2007; Naka-
gawa et al., 2008; Okita et al., 2007;
Takahashi et al., 2007; Takahashi and
Yamanaka, 2006; Wernig et al., 2007,
2008; Yu et al., 2007). For the iPS cell ap-
proach to be clinically relevant, several
challenges remain to be addressed, in-
cluding the elimination of the risks and
drawbacks associated with the current
iPS cell method, such as the use of ge-
netic manipulation and the low efficiency
and slow kinetics of induction. Recent
studies have shown that c-Myc, one of
the four genes originally thought to be
required for iPS cell generation, is dis-
pensable, but in its absence the reprog-
ramming efficiency is reduced (Nakagawa
et al., 2008; Wernig et al., 2008). Here, we
have explored two approaches toward
identifying conditions that can replace
viral transduction of oncogenic transcrip-
tion factors (TFs) and enhance reprog-
ramming efficiency. In one, we have found
that neural progenitor cells can be reprog-
rammed with fewer genetic manipulations
than previously reported somatic cells,
and in the other we have found that small
molecules may be able to replace viral in-
tegration of certain transcription factors
and promote the reprogramming process.
A number of adult stem/progenitor cells
from different tissues are accessible for
manipulation, but we focused our efforts
on neural progenitor cells (NPCs) for the
following reasons. (1) In contrast to het-
erogeneous primary fibroblast culture
(e.g., MEFs) that may contain various
types of stem/progenitor cells, NPCs are
a relatively defined population of cellsand can be clonally expanded under
chemically defined conditions. (2) NPCs
endogenously express specific Sox
genes (e.g., Sox1 or Sox2) (Blelloch
et al., 2006), which, although at lower level
than when overexpressed, might be suffi-
cient in conjunction with other exogenous
reprogramming TFs for generating iPS
cells. (3) NPCs or cells expressing Sox
genes may be isolated from other tissues
(Fernandes et al., 2004; Seaberg et al.,
2004) and expanded in vitro. For screen-
ing purposes, we chose to use mESC-de-
rived NPCs containing a GFP-IRES-Puro/
GiP reporter under the control of theOct3/
4 regulatory elements, as mESCs can be
grown in large quantities and their differ-
entiation to a homogenous population of
NPCs is well defined (Conti et al., 2005).
The resulting NPCs, which were homoge-
nous based on cell morphology and neu-
ral marker expression, GFP and puromy-
cin sensitive, were plated in a monolayer
culture and transduced with combina-
tions of four, three, or two of the four fac-
tors originally used for reprogramming:
Oct3/4, Sox2, Klf4, and c-Myc (Takahashi
and Yamanaka, 2006). The transduced
cells were then treated with individual
small molecules from a small collection
of known compounds in a 6-well format.
The transduced NPCs were treated with
the compounds for 10 days before puro-
mycin treatment. The number of GFP+
and puromycin-resistant colonies was
evaluated 4 days after puromycin treat-
ment. For this assay, NPCs transduced
with the four genes and treated with no
compound were used as a positive con-
trol. Compounds that generated 2-fold
more GFP+ colonies from NPCs trans-
duced with different gene combination,
as compared with the noncompound-
treated transduced NPCs, were identified
as hits. To validate the results obtained,Cell Stemwe used late-passage primary mouse
CNS NPCs (Tae Do et al., 2007) that
were derived from the fetal brain of
OG2+//ROSA26+/ transgenic mice,
which contain an Oct4-GFP reporter. Al-
though it is unlikely that our initial screen-
ing system contained any contaminating
ESCs, cells derived from a nonpluripotent
tissue provide an important validation of
our results. Similar culture conditions
and reprogramming assays were per-
formed with the fetal NPCs, and GFP+ col-
onies were isolated and characterized by
staining for Oct3/4, Nanog, SSEA1, and
alkaline phosphatase activity (ALP).
We first focused our characterization
efforts on two striking new conditions.
As hypothesized, NPCs, which express
Sox2 gene endogenously, could be re-
programmed after viral transduction of
only Oct3/4 and Klf4 and generated iPS
cell colonies within 10–14 days. Although
the reprogramming efficiency, 1.5 ± 0.7
GFP+ colonies per 3.5 3 104 cells, was
lower than when four factors were used,
12 ± 1.4 per 3.5 3 104 cells (Figure 1A),
it is interesting to note that the kinetics
of reprogramming by Oct3/4 and Klf4
was not significantly slower than that in-
duced by the original four genes. This
contrasts with recent observations that
omitting c-Myc in generating iPS cells
from MEFs causes reprogramming to be
significantly slower than when c-Myc is
present, even though MEFs endoge-
nously express c-Myc (Nakagawa et al.,
2008; Wernig et al., 2008).
We also found that the small molecule
BIX-01294 (BIX), an inhibitor of the G9a
histone methyltransferase (Kubicek
et al., 2007), can improve the reprogram-
ming efficiency in NPCs transduced with
Oct3/4-Klf4 to a level comparable to
transduction with all four factors; we ob-
tained 12 ± 1.41 iPS cell colonies perCell 2, June 2008 ª2008 Elsevier Inc. 525
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transduction and BIX, compared to 8 ±
1.4 colonies per 3.53 104 NPCs when us-
ing the original four factors, and 1.5 ± 0.7
colonies per 3.53 104 NPCs with Oct3/4-
Klf4 alone (Figure 1A). Although the overall
efficiency was improved, the reprogram-
ming process was not significantly short-
ened by the presence of this small mole-
cule. Nevertheless, in this particular
setting, this single small molecule, BIX,
appears to be able to functionally replace
viral transduction with c-Myc and Sox2.
Around day 14, iPS cells generated
from Oct3/4-Klf4 viral transduction and
BIX treatment (Figure S1Aa available on-
line) can be readily expanded in conven-
tional mESC culture conditions on MEF
feeder cells in the presence of LIF. These
cells grow as compact, domed colonies
(Figure 1Ba) and homogenously express
typical pluripotency markers such as
Oct3/4, Nanog, SSEA1, and ALP at com-
parable levels to mESCs as assessed by
immunocyto/histochemistry (Figure 1Bb).
These iPS cells were propagated over
ten passages and differentiated effec-
tively into derivatives of the three primary
germ layers. Under standard embryoid
body or directed differentiation methods,
markers indicative of neurons (bIII-tubulin),
beating cardiomyocytes (cardiac tropo-
nin), and pancreatic or hepatic cells
(Pdx1 or Albumin) (Figure 1Ca) could be
observed. Most importantly, at passage 8
these iPS cells could incorporate efficiently
into the inner cell mass (ICM) of a blasto-
cyst (Figure S1Ab) after aggregation with
an eight cell embryo. They could also gen-
erate high-grade chimeras (Figure 1Cb
and Figure S1Ac) after the aggregated
embryos were transplanted into mice, in-
cluding Oct4-GFP+ cells in female gonad
tissue in 13.5 dpc embryos (Figure 1Cc),
suggestive of iPS cell contribution to the
germline. Thus, iPS cells generated from
NPCs by Oct3/4-Klf4 viral transduction
with simultaneous BIX treatment have sim-
ilar characteristics to the original iPS cells
generated with four factors.
An important question in the field is
whether endogenous or exogenous ex-
pression of particular transcription factors
is required for generating iPS cells from
somatic cells. Recent reprogramming
studies on generating human iPS cells
from fibroblasts have shown that, al-
though exogenous expression of Klf4
and c-Myc can be replaced with Nanog
Figure 1. Generation of iPS Cells from Primary Fetal NPCs by Oct4/Klf4 Viral Transduction
and BIX01294 Treatment
(A) A comparison of the number of GFP+ iPS cell colonies generated from 3.53 104 primary OG2 NPCs by
retroviral transduction of Oct3/4-Klf4/Sox2/c-Myc, Oct3/4-Klf4/Sox2, or Oct3/4-Klf4 with or without
BIX01294 treatment.
(B) iPS cells generated by Oct4/Klf4 viral transduction and BIX01294 treatment. (a) iPS cells generated by
Oct4/Klf4 transduction and BIX01294 treatment can be propagated over several passages on MEF
feeders in mESC growth media without continued BIX01294 treatment. (b) These iPS cells maintain char-
acteristic mESC-colony morphology and express pluripotency markers, including ALP, Oct4, Nanog, and
SSEA1.
(C) In vitro and in vivo developmental pluripotency of iPS cells generated from primary NPCs by Oct3/4-
Klf4 viral transduction and BIX01294 treatment. (a) iPS cells can effectively differentiate into characteristic
neurons (bIII tubulin/Tuj1+), beating cardiomyocytes (cardiac troponin T/CT3+) and pancreatic or hepatic
cells (Pdx1+ or Albumin+). (b) The aggregated embryo generated a high-grade chimeric embryo (13.5 dpc)
after transfer into a pseudopregnant mouse (lacZ staining of the embryo section shows contribution from
iPS cells that are OG2+//ROSA26+/). (c) Such iPS cells appeared to contribute to the germline cells
(Oct4-GFP+) in female gonadal tissues isolated from chimeric embryos at 13.5 dpc.
Bar graphs and statistical analyses were performed by standard t tests with Excel software.526 Cell Stem Cell 2, June 2008 ª2008 Elsevier Inc.
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of Oct3/4 and Sox2 seems to be re-
quired based on all iPS cell studies
published so far. However, we found
that viral transduction of fetal NPCs
with Klf4, Sox2, and c-Myc (KSM) in
conjunction with BIX treatment, but
without Oct3/4 overexpression, can
generate iPS cells, albeit at a low fre-
quency (1.5 ± 0.7 colonies per 3.5 3
104 fetal NPCs) (Figure 2A and
Figure S1Ba). When virally trans-
duced with KSM in the absence of
BIX, fetal NPCs failed to generate
any iPS cell colonies. KSM-BIX iPS
cells can be stably expanded for
over ten passages in conventional
mESC growth conditions without
BIX. These cells maintain characteris-
tic mESC morphology (Figure 2Ba)
and homogenously express typical
pluripotency markers (Figure 2Bb).
They were also able to incorporate ef-
ficiently into the ICM of a blastocyst
after aggregation with an eight cell
embryo and led to high-grade chime-
rism (Figure 2C and Figure S1Bb)
once the aggregated embryos were
transplanted into mice. These cells
also generated GFP+ cells in the fe-
mal gonad tissue of 13.5 dpc em-
bryos, suggestive of iPS cell contribu-
tion to the germline (Figure 2Cc). It
should be noted that the reprogram-
ming efficiency in the absence of
Oct3/4 expression is relatively low
(see above). Although NPCs endoge-
nously express Sox2, we found that
exogenous Sox2 expression is still re-
quired for reprogramming in the ab-
sence of Oct3/4. When NPCs were
transduced with Klf4/c-Myc without
Sox2, no GFP+ iPS cells were ob-
served in this assay (data not shown).
Due to the very low efficiency of re-
programming, iPS cells are typically
selected by using genetically modi-
fied somatic cell lines containing re-
porters (e.g., Neo/Puro or GFP) that
are under the control of the regulatory
elements of a pluripotency marker.
iPS cells can also be manually iso-
lated based on colony morphology
(Blelloch et al., 2007). Although the
latter method can be applied to ge-
netically unmodified cells, it is a more te-
dious and a less reliable technique, and
only small fractions of the selected colo-
nies eventually become true iPS cells.
Thus, an alternative selection strategy
for genetically unmodified cells would be
highly desirable. We observed that the
application of a specific small molecule
MEK inhibitor, PD0325901, at late
stage of reprogramming (e.g., after
Oct4-GFP weak activation) serves
as an excellent selection strategy
when generating iPS cells from virally
transduced NPCs. We found that
when added 7–9 days after Oct3/4-
Klf4 viral infection, when GFP+ cells
first appear, and continuously for 5
days, PD0325901 inhibits growth of
non-iPS cell colonies and promotes
growth of reprogrammed iPS cells,
leading to larger colonies that ex-
press Oct3/4 at a higher level and
more homogenously than nontreated
iPS cells (Figure S2). The mechanistic
basis of this observation might be
that MEK is required for cell-cycle
progression of somatic cells, but not
mESCs. MEK inhibition also prevents
mES cell differentiation (Burdon et al.,
1999) and induces reprogramming of
lineage-restricted cells (Chen et al.,
2007; Chen et al., 2004), further con-
tributing to stabilization of the iPS
cell state.
The results presented here have
a number of important implications.
First, they suggest that endogenous
expression levels of critical genes re-
quired for reprogramming by some
tissue-specific somatic cells may be
sufficient to replace the correspond-
ing exogenous gene expression via
viral transduction for generating iPS
cells. It is important to note that our
experiments only involved the use of
fetal NPCs, and it is possible that
adult cells may not respond in the
same way. Nevertheless, they sug-
gest an alternative strategy for gener-
ating iPS cells from somatic cells with
less genetic manipulation by using
readily accessible cells that express
reprogramming genes endogenously
via intrinsic tissue specificity and/or
ex vivo culture manipulation. Second,
our study is a proof-of-principle dem-
onstration that rationally designed
cell-based screens can identify small
molecules to replace viral transduc-
tion of certain transcription factors,
improve reprogramming efficiency,
or serve as a selection condition for
generating iPS cells. Small mole-
cule-based approaches for generating
iPS cells would reduce the risks associ-
ated with oncogene transduction and
pave the way for an efficient and
Figure 2. Generation of iPS Cells from Primary
Fetal NPCs by Klf4/Sox2/c-Myc Viral Transduction
and BIX01294 Treatment
(A) Bar graph showing the number of GFP+ iPS cell colo-
nies generated from 3.5 3 104 primary OG2 NPCs by
retroviral transduction of Klf4/Sox2/c-Myc with or without
BIX01294 treatment.
(B) iPS cells from NPCs were transduced with Klf4/Sox2/c-
Myc and treated with BIX01294. (a) Phase contrast and
green fluorescence photograph of iPS cells generated by
Klf4/Sox2/c-Myc transduction and BIX01294 treatment af-
ter long-term culture on MEF feeders in the mESC growth
media without continued BIX01294 treatment. (b) These
iPS cells maintain characteristic mESC-colony morphol-
ogy and express pluripotency markers, including ALP,
Oct4, Nanog, and SSEA1.
(C) (a)The aggregated embryo generated a high-grade chi-
meric embryo (13.5 dpc) after transfer into a pseudopreg-
nant mouse (lacZ staining of the embryo section showing
contribution from the iPS cells generated from OG2+//
ROSA26+/ NPCs). (b) Such iPS cells appeared to contrib-
ute to germline cell development (Oct4-GFP+) in
female gonadal tissues isolated from 13.5 dpc chimeric
embryos.
Bar graphs and statistical analyses were performed by
standard t tests with Excel software.Cell Stem Cell 2, June 2008 ª2008 Elsevier Inc. 527
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in contrast to the gain-of-function ap-
proach in generating iPS cells, use of spe-
cific small molecule inhibitors suggests
that loss of function of certain genes
may be an effective mechanism for gener-
ating iPS cells. More specifically, the ob-
served effect of BIX identified a specific
epigenetic mechanism/target in generat-
ing iPS cells, i.e., inhibition of G9a-medi-
ated H3K9me2 (Kubicek et al., 2007).
This is consistent with the previous find-
ings that the repressive H3K9 methylation
is associated withOct3/4 inactivation dur-
ing differentiation (Feldman et al., 2006)
and that histone lysine methylation is dy-
namic and regulated by HMTases and ly-
sine demethylases. BIX may function to
facilitate a shift in the epigenetic balance
from Oct3/4 silencing to active transcrip-
tion. Fourth, exploiting the differences be-
tween the response of somatic cells and
ESCs to small molecules represents a
strategy for selecting iPS cells, as exem-
plified by the use of an MEK inhibitor to
stabilize and select fully reprogrammed
iPS cells. Our hope is that future applica-
tion of these types of strategies will further
improve our understanding of iPS cell
generation. The use of additional small
molecules or other nongenetic methods
that could replace the function of the re-
maining transduced TFs and/or improve
reprogramming could ultimately allow
the generation of iPS cells or multipotent
tissue-specific stem cells in completely
chemically defined conditions without
any genetic modification.528 Cell Stem Cell 2, June 2008 ª2008 ElseSUPPLEMENTAL DATA
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